Evidence map›Paper›PMID 31619020›Full record

ArticleMolecules (Basel, Switzerland)2019

Synthesis and Glycosidase Inhibition of Broussonetine M and Its Analogues.

Qing-Kun Wu, Kyoko Kinami, Atsushi Kato, Yi-Xian Li, George W J Fleet, Chu-Yi Yu, Yue-Mei Jia

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Qing-Kun WuBeijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. lsqkwu@iccas.ac.cn.
Kyoko KinamiDepartment of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. tamarali@iccas.ac.cn.
Atsushi KatoDepartment of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. kato@med.u-toyama.ac.jp.
Yi-Xian LiBeijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. tamarali@iccas.ac.cn.
George W J FleetChemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, OX13TA Oxford, UK. george.fleet@sjc.ox.ac.uk.
Chu-Yi YuBeijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. yucy@iccas.ac.cn.
Yue-Mei JiaBeijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. jiayuemei@iccas.ac.cn.
Chinese Academy of Sciences · CNToyama University Hospital · JPUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cross-metathesis (CM) and Keck asymmetric allylation, which allows access to defined stereochemistry of a remote side chain hydroxyl group, are the key steps in a versatile synthesis of broussonetine M (

Indexed as

Enzyme InhibitorsGlycoside HydrolasesMagnetic Resonance SpectroscopyMolecular StructurePyrrolidinesStructure-Activity Relationshipbroussonetine MEnzyme InhibitorsGlycoside HydrolasesPyrrolidinesanaloguebroussonetine Mglycosidase inhibitionstructure-activity relationshipsynthesis

Identifiers

PMID31619020
PMCPMC6832352
OpenAlexW2980834982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.